<DOC>
	<DOC>NCT02571907</DOC>
	<brief_summary>The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.</brief_summary>
	<brief_title>PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Iliac Aneurysm</mesh_term>
	<criteria>An aortioiliac or iliac aneurysm An unsuitable distal sealing site for a traditional Zenith iliac leg graft within the common lilac artery Less than 18 years of age Inability or refusal to give informed consent Disease considerations that would compromise patient safety or study outcomes Pregnant, breastfeeding or planning on becoming pregnant prior to completion of the study Unwilling or unable to comply with the followup schedule Simultaneously participating in another investigative device or drug study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Zenith aortoiliac aneurysm</keyword>
	<keyword>Iliac aneurysm</keyword>
	<keyword>Branch</keyword>
	<keyword>Connections</keyword>
	<keyword>Endovascular graft</keyword>
	<keyword>Graft-iliac bifurcation</keyword>
	<keyword>Aneurysm</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
</DOC>